Back to mobile site
Get it on Google Play

NeOnc gets UAE clearance for NEO212 brain tumor drug trial

June 16, 2026 9:00 AM EDT Send to a Friend
NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) announced that the Department of Health – Abu Dhabi has granted Investigational New Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login